TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

Michael D. Gallagher, Eunran Suh, Murray Grossman, Lauren Elman, Leo McCluskey, John C. Van Swieten, Safa Al-Sarraj, Manuela Neumann, Ellen Gelpi, Bernardino Ghetti, Jonathan D. Rohrer, Glenda Halliday, Christine Van Broeckhoven, Danielle Seilhean, Pamela J. Shaw, Matthew P. Frosch, Irina Alafuzoff, Anna Antonell, Nenad Bogdanovic, William BrooksNigel J. Cairns, Johnathan Cooper-Knock, Carl Cotman, Patrick Cras, Marc Cruts, Peter P. De Deyn, Charles Decarli, Carol Dobson-Stone, Sebastiaan Engelborghs, Nick Fox, Douglas Galasko, Marla Gearing, Ilse Gijselinck, Jordan Grafman, Päivi Hartikainen, Kimmo J. Hatanpaa, J. Robin Highley, John Hodges, Christine Hulette, Paul G. Ince, Lee Way Jin, Janine Kirby, Julia Kofler, Jillian Kril, John B J Kwok, Allan Levey, Andrew Lieberman, Albert Llado, Jean Jacques Martin, Eliezer Masliah, Christopher J. McDermott, Ann McKee, Catriona McLean, Simon Mead, Carol A. Miller, Josh Miller, David G. Munoz, Jill Murrell, Henry Paulson, Olivier Piguet, Martin Rossor, Raquel Sanchez-Valle, Mary Sano, Julie Schneider, Lisa C. Silbert, Salvatore Spina, Julie Van Der Zee, Tim Van Langenhove, Jason Warren, Stephen B. Wharton, Charles L. White, Randall L. Woltjer, John Q. Trojanowski, Virginia M Y Lee, Vivianna Van Deerlin, Alice S. Chen-Plotkin

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis, and may be the most common genetic cause of both neurodegenerative diseases. Genetic variants at TMEM106B influence risk for the most common neuropathological subtype of FTLD, characterized by inclusions of TAR DNA-binding protein of 43 kDa (FTLD-TDP). Previous reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease. Here, we report that rs1990622 genotype affects age at death in a single-site discovery cohort of FTLD patients with C9orf72 expansions (n = 14), with the major allele correlated with later age at death (p = 0.024). We replicate this modifier effect in a 30-site international neuropathological cohort of FTLD-TDP patients with C9orf72 expansions (n = 75), again finding that the major allele associates with later age at death (p = 0.016), as well as later age at onset (p = 0.019). In contrast, TMEM106B genotype does not affect age at onset or death in 241 FTLD-TDP cases negative for GRN mutations or C9orf72 expansions. Thus, TMEM106B is a genetic modifier of FTLD with C9orf72 expansions. Intriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease.

Original languageEnglish
Pages (from-to)407-418
Number of pages12
JournalActa Neuropathologica
Volume127
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Frontotemporal Lobar Degeneration
Chromosomes, Human, Pair 9
Open Reading Frames
Age of Onset
Alleles
Genotype
Neurodegenerative Diseases
Mutation
Amyotrophic Lateral Sclerosis
DNA-Binding Proteins

Keywords

  • Amyotrophic lateral sclerosis
  • C9orf72
  • Frontotemporal dementia
  • Frontotemporal lobar degeneration
  • Genetic modifier
  • TMEM106B

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cellular and Molecular Neuroscience

Cite this

Gallagher, M. D., Suh, E., Grossman, M., Elman, L., McCluskey, L., Van Swieten, J. C., ... Chen-Plotkin, A. S. (2014). TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica, 127(3), 407-418. https://doi.org/10.1007/s00401-013-1239-x

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. / Gallagher, Michael D.; Suh, Eunran; Grossman, Murray; Elman, Lauren; McCluskey, Leo; Van Swieten, John C.; Al-Sarraj, Safa; Neumann, Manuela; Gelpi, Ellen; Ghetti, Bernardino; Rohrer, Jonathan D.; Halliday, Glenda; Van Broeckhoven, Christine; Seilhean, Danielle; Shaw, Pamela J.; Frosch, Matthew P.; Alafuzoff, Irina; Antonell, Anna; Bogdanovic, Nenad; Brooks, William; Cairns, Nigel J.; Cooper-Knock, Johnathan; Cotman, Carl; Cras, Patrick; Cruts, Marc; De Deyn, Peter P.; Decarli, Charles; Dobson-Stone, Carol; Engelborghs, Sebastiaan; Fox, Nick; Galasko, Douglas; Gearing, Marla; Gijselinck, Ilse; Grafman, Jordan; Hartikainen, Päivi; Hatanpaa, Kimmo J.; Highley, J. Robin; Hodges, John; Hulette, Christine; Ince, Paul G.; Jin, Lee Way; Kirby, Janine; Kofler, Julia; Kril, Jillian; Kwok, John B J; Levey, Allan; Lieberman, Andrew; Llado, Albert; Martin, Jean Jacques; Masliah, Eliezer; McDermott, Christopher J.; McKee, Ann; McLean, Catriona; Mead, Simon; Miller, Carol A.; Miller, Josh; Munoz, David G.; Murrell, Jill; Paulson, Henry; Piguet, Olivier; Rossor, Martin; Sanchez-Valle, Raquel; Sano, Mary; Schneider, Julie; Silbert, Lisa C.; Spina, Salvatore; Van Der Zee, Julie; Van Langenhove, Tim; Warren, Jason; Wharton, Stephen B.; White, Charles L.; Woltjer, Randall L.; Trojanowski, John Q.; Lee, Virginia M Y; Van Deerlin, Vivianna; Chen-Plotkin, Alice S.

In: Acta Neuropathologica, Vol. 127, No. 3, 03.2014, p. 407-418.

Research output: Contribution to journalArticle

Gallagher, MD, Suh, E, Grossman, M, Elman, L, McCluskey, L, Van Swieten, JC, Al-Sarraj, S, Neumann, M, Gelpi, E, Ghetti, B, Rohrer, JD, Halliday, G, Van Broeckhoven, C, Seilhean, D, Shaw, PJ, Frosch, MP, Alafuzoff, I, Antonell, A, Bogdanovic, N, Brooks, W, Cairns, NJ, Cooper-Knock, J, Cotman, C, Cras, P, Cruts, M, De Deyn, PP, Decarli, C, Dobson-Stone, C, Engelborghs, S, Fox, N, Galasko, D, Gearing, M, Gijselinck, I, Grafman, J, Hartikainen, P, Hatanpaa, KJ, Highley, JR, Hodges, J, Hulette, C, Ince, PG, Jin, LW, Kirby, J, Kofler, J, Kril, J, Kwok, JBJ, Levey, A, Lieberman, A, Llado, A, Martin, JJ, Masliah, E, McDermott, CJ, McKee, A, McLean, C, Mead, S, Miller, CA, Miller, J, Munoz, DG, Murrell, J, Paulson, H, Piguet, O, Rossor, M, Sanchez-Valle, R, Sano, M, Schneider, J, Silbert, LC, Spina, S, Van Der Zee, J, Van Langenhove, T, Warren, J, Wharton, SB, White, CL, Woltjer, RL, Trojanowski, JQ, Lee, VMY, Van Deerlin, V & Chen-Plotkin, AS 2014, 'TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions', Acta Neuropathologica, vol. 127, no. 3, pp. 407-418. https://doi.org/10.1007/s00401-013-1239-x
Gallagher, Michael D. ; Suh, Eunran ; Grossman, Murray ; Elman, Lauren ; McCluskey, Leo ; Van Swieten, John C. ; Al-Sarraj, Safa ; Neumann, Manuela ; Gelpi, Ellen ; Ghetti, Bernardino ; Rohrer, Jonathan D. ; Halliday, Glenda ; Van Broeckhoven, Christine ; Seilhean, Danielle ; Shaw, Pamela J. ; Frosch, Matthew P. ; Alafuzoff, Irina ; Antonell, Anna ; Bogdanovic, Nenad ; Brooks, William ; Cairns, Nigel J. ; Cooper-Knock, Johnathan ; Cotman, Carl ; Cras, Patrick ; Cruts, Marc ; De Deyn, Peter P. ; Decarli, Charles ; Dobson-Stone, Carol ; Engelborghs, Sebastiaan ; Fox, Nick ; Galasko, Douglas ; Gearing, Marla ; Gijselinck, Ilse ; Grafman, Jordan ; Hartikainen, Päivi ; Hatanpaa, Kimmo J. ; Highley, J. Robin ; Hodges, John ; Hulette, Christine ; Ince, Paul G. ; Jin, Lee Way ; Kirby, Janine ; Kofler, Julia ; Kril, Jillian ; Kwok, John B J ; Levey, Allan ; Lieberman, Andrew ; Llado, Albert ; Martin, Jean Jacques ; Masliah, Eliezer ; McDermott, Christopher J. ; McKee, Ann ; McLean, Catriona ; Mead, Simon ; Miller, Carol A. ; Miller, Josh ; Munoz, David G. ; Murrell, Jill ; Paulson, Henry ; Piguet, Olivier ; Rossor, Martin ; Sanchez-Valle, Raquel ; Sano, Mary ; Schneider, Julie ; Silbert, Lisa C. ; Spina, Salvatore ; Van Der Zee, Julie ; Van Langenhove, Tim ; Warren, Jason ; Wharton, Stephen B. ; White, Charles L. ; Woltjer, Randall L. ; Trojanowski, John Q. ; Lee, Virginia M Y ; Van Deerlin, Vivianna ; Chen-Plotkin, Alice S. / TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. In: Acta Neuropathologica. 2014 ; Vol. 127, No. 3. pp. 407-418.
@article{0ae047b8af3d45a3a4f615db8e19bdf8,
title = "TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions",
abstract = "Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis, and may be the most common genetic cause of both neurodegenerative diseases. Genetic variants at TMEM106B influence risk for the most common neuropathological subtype of FTLD, characterized by inclusions of TAR DNA-binding protein of 43 kDa (FTLD-TDP). Previous reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease. Here, we report that rs1990622 genotype affects age at death in a single-site discovery cohort of FTLD patients with C9orf72 expansions (n = 14), with the major allele correlated with later age at death (p = 0.024). We replicate this modifier effect in a 30-site international neuropathological cohort of FTLD-TDP patients with C9orf72 expansions (n = 75), again finding that the major allele associates with later age at death (p = 0.016), as well as later age at onset (p = 0.019). In contrast, TMEM106B genotype does not affect age at onset or death in 241 FTLD-TDP cases negative for GRN mutations or C9orf72 expansions. Thus, TMEM106B is a genetic modifier of FTLD with C9orf72 expansions. Intriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease.",
keywords = "Amyotrophic lateral sclerosis, C9orf72, Frontotemporal dementia, Frontotemporal lobar degeneration, Genetic modifier, TMEM106B",
author = "Gallagher, {Michael D.} and Eunran Suh and Murray Grossman and Lauren Elman and Leo McCluskey and {Van Swieten}, {John C.} and Safa Al-Sarraj and Manuela Neumann and Ellen Gelpi and Bernardino Ghetti and Rohrer, {Jonathan D.} and Glenda Halliday and {Van Broeckhoven}, Christine and Danielle Seilhean and Shaw, {Pamela J.} and Frosch, {Matthew P.} and Irina Alafuzoff and Anna Antonell and Nenad Bogdanovic and William Brooks and Cairns, {Nigel J.} and Johnathan Cooper-Knock and Carl Cotman and Patrick Cras and Marc Cruts and {De Deyn}, {Peter P.} and Charles Decarli and Carol Dobson-Stone and Sebastiaan Engelborghs and Nick Fox and Douglas Galasko and Marla Gearing and Ilse Gijselinck and Jordan Grafman and P{\"a}ivi Hartikainen and Hatanpaa, {Kimmo J.} and Highley, {J. Robin} and John Hodges and Christine Hulette and Ince, {Paul G.} and Jin, {Lee Way} and Janine Kirby and Julia Kofler and Jillian Kril and Kwok, {John B J} and Allan Levey and Andrew Lieberman and Albert Llado and Martin, {Jean Jacques} and Eliezer Masliah and McDermott, {Christopher J.} and Ann McKee and Catriona McLean and Simon Mead and Miller, {Carol A.} and Josh Miller and Munoz, {David G.} and Jill Murrell and Henry Paulson and Olivier Piguet and Martin Rossor and Raquel Sanchez-Valle and Mary Sano and Julie Schneider and Silbert, {Lisa C.} and Salvatore Spina and {Van Der Zee}, Julie and {Van Langenhove}, Tim and Jason Warren and Wharton, {Stephen B.} and White, {Charles L.} and Woltjer, {Randall L.} and Trojanowski, {John Q.} and Lee, {Virginia M Y} and {Van Deerlin}, Vivianna and Chen-Plotkin, {Alice S.}",
year = "2014",
month = "3",
doi = "10.1007/s00401-013-1239-x",
language = "English",
volume = "127",
pages = "407--418",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

AU - Gallagher, Michael D.

AU - Suh, Eunran

AU - Grossman, Murray

AU - Elman, Lauren

AU - McCluskey, Leo

AU - Van Swieten, John C.

AU - Al-Sarraj, Safa

AU - Neumann, Manuela

AU - Gelpi, Ellen

AU - Ghetti, Bernardino

AU - Rohrer, Jonathan D.

AU - Halliday, Glenda

AU - Van Broeckhoven, Christine

AU - Seilhean, Danielle

AU - Shaw, Pamela J.

AU - Frosch, Matthew P.

AU - Alafuzoff, Irina

AU - Antonell, Anna

AU - Bogdanovic, Nenad

AU - Brooks, William

AU - Cairns, Nigel J.

AU - Cooper-Knock, Johnathan

AU - Cotman, Carl

AU - Cras, Patrick

AU - Cruts, Marc

AU - De Deyn, Peter P.

AU - Decarli, Charles

AU - Dobson-Stone, Carol

AU - Engelborghs, Sebastiaan

AU - Fox, Nick

AU - Galasko, Douglas

AU - Gearing, Marla

AU - Gijselinck, Ilse

AU - Grafman, Jordan

AU - Hartikainen, Päivi

AU - Hatanpaa, Kimmo J.

AU - Highley, J. Robin

AU - Hodges, John

AU - Hulette, Christine

AU - Ince, Paul G.

AU - Jin, Lee Way

AU - Kirby, Janine

AU - Kofler, Julia

AU - Kril, Jillian

AU - Kwok, John B J

AU - Levey, Allan

AU - Lieberman, Andrew

AU - Llado, Albert

AU - Martin, Jean Jacques

AU - Masliah, Eliezer

AU - McDermott, Christopher J.

AU - McKee, Ann

AU - McLean, Catriona

AU - Mead, Simon

AU - Miller, Carol A.

AU - Miller, Josh

AU - Munoz, David G.

AU - Murrell, Jill

AU - Paulson, Henry

AU - Piguet, Olivier

AU - Rossor, Martin

AU - Sanchez-Valle, Raquel

AU - Sano, Mary

AU - Schneider, Julie

AU - Silbert, Lisa C.

AU - Spina, Salvatore

AU - Van Der Zee, Julie

AU - Van Langenhove, Tim

AU - Warren, Jason

AU - Wharton, Stephen B.

AU - White, Charles L.

AU - Woltjer, Randall L.

AU - Trojanowski, John Q.

AU - Lee, Virginia M Y

AU - Van Deerlin, Vivianna

AU - Chen-Plotkin, Alice S.

PY - 2014/3

Y1 - 2014/3

N2 - Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis, and may be the most common genetic cause of both neurodegenerative diseases. Genetic variants at TMEM106B influence risk for the most common neuropathological subtype of FTLD, characterized by inclusions of TAR DNA-binding protein of 43 kDa (FTLD-TDP). Previous reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease. Here, we report that rs1990622 genotype affects age at death in a single-site discovery cohort of FTLD patients with C9orf72 expansions (n = 14), with the major allele correlated with later age at death (p = 0.024). We replicate this modifier effect in a 30-site international neuropathological cohort of FTLD-TDP patients with C9orf72 expansions (n = 75), again finding that the major allele associates with later age at death (p = 0.016), as well as later age at onset (p = 0.019). In contrast, TMEM106B genotype does not affect age at onset or death in 241 FTLD-TDP cases negative for GRN mutations or C9orf72 expansions. Thus, TMEM106B is a genetic modifier of FTLD with C9orf72 expansions. Intriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease.

AB - Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis, and may be the most common genetic cause of both neurodegenerative diseases. Genetic variants at TMEM106B influence risk for the most common neuropathological subtype of FTLD, characterized by inclusions of TAR DNA-binding protein of 43 kDa (FTLD-TDP). Previous reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease. Here, we report that rs1990622 genotype affects age at death in a single-site discovery cohort of FTLD patients with C9orf72 expansions (n = 14), with the major allele correlated with later age at death (p = 0.024). We replicate this modifier effect in a 30-site international neuropathological cohort of FTLD-TDP patients with C9orf72 expansions (n = 75), again finding that the major allele associates with later age at death (p = 0.016), as well as later age at onset (p = 0.019). In contrast, TMEM106B genotype does not affect age at onset or death in 241 FTLD-TDP cases negative for GRN mutations or C9orf72 expansions. Thus, TMEM106B is a genetic modifier of FTLD with C9orf72 expansions. Intriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease.

KW - Amyotrophic lateral sclerosis

KW - C9orf72

KW - Frontotemporal dementia

KW - Frontotemporal lobar degeneration

KW - Genetic modifier

KW - TMEM106B

UR - http://www.scopus.com/inward/record.url?scp=84896738170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896738170&partnerID=8YFLogxK

U2 - 10.1007/s00401-013-1239-x

DO - 10.1007/s00401-013-1239-x

M3 - Article

C2 - 24442578

AN - SCOPUS:84896738170

VL - 127

SP - 407

EP - 418

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 3

ER -